Martingale Asset Management L P boosted its holdings in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 3.8% during the first quarter, Holdings Channel.com reports. The firm owned 24,921 shares of the medical instruments supplier’s stock after acquiring an additional 907 shares during the period. Martingale Asset Management L P’s holdings in Haemonetics were […]
In an exciting development for investors, Haemonetics (NYSE:HAE) received an upgrade by StockNews.com from a “buy” rating to a “strong-buy” rating on August 25, 2023. On Friday, shares of HAE opened at $86.43. The company’s 50-day moving average price stands at $87.87, while the 200-day moving average price is $84.26. It’s worth noting that Haemonetics […] The post Haemonetics Receives Strong-Buy Rating and Shows Potential for Long-Term Gains appeared first on Best Stocks .
Haemonetics Co. (NYSE:HAE – Free Report) – Equities research analysts at Zacks Research reduced their Q4 2024 earnings per share (EPS) estimates for shares of Haemonetics in a report issued on Monday, August 21st. Zacks Research analyst R. Anand now anticipates that the medical instruments supplier will post earnings of $0.88 per share for the […]